Monro, Inc. (MNRO) stock analysis
Close on Nov 11, 2026Market cap $361.20MP/E –Yield 9.71%
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed11 of 30 checks passed
Monro passes 11 of the 30 checks behind our score; 10 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 4/6
- Growth
- 1/6
- Past performance
- 1/6
- Financial health
- 1/6
- Dividend
- 4/6
What stands out
Margin of safety over 20%
The price is 46.8% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $11.53 is below our fair value estimate of $21.65.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 32.5% of total debt.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
What to watch
Earnings shrank over 5 years
Net income shrank 42.4% a year on average over the last five fiscal years.
Revenue growing under 10% a year
Revenue grew -4.4% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -70.8% a year over the last three fiscal years.
Elevated bankruptcy risk
The Altman Z-score is 1.31; above 3 is the safe zone and below 1.8 the distress zone.
Valuation4/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA below its 5-year median
Monro's EV/EBITDA of 5.9 is below its 5-year median of 8.2.
P/S below the industry
Monro's price-to-sales of 0.32 is below the Consumer discretionary median of 0.92 (book value is negative, so we use sales).
Trading below fair value
The share price of $11.53 is below our fair value estimate of $21.65.
Margin of safety over 20%
The price is 46.8% below fair value, more than the 20% cushion we look for.
Growth1/6
Revenue growing under 10% a year
Revenue grew -4.4% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -70.8% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew -4.4% over the last twelve months; the Consumer discretionary median is 5.0%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin improving
Gross margin was 34.8% over the last twelve months, against 34.6% a year earlier.
Past performance1/6
Return on equity
Needs positive equity and five years of results.
Return on invested capital
Needs operating income and invested capital.
Return on equity against the industry
Needs positive equity.
Earnings shrank over 5 years
Net income shrank 42.4% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 0.1% over the last twelve months, against a 5-year average of 2.0%.
Net margin above the industry
Monro's net margin of 0.1% is above the Consumer discretionary median of -5.4%.
Financial health1/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 32.5% of total debt.
Interest coverage
Interest expense is not reported separately.
Short-term assets don't cover short-term debts
Current assets are 0.48 times current liabilities.
Elevated bankruptcy risk
The Altman Z-score is 1.31; above 3 is the safe zone and below 1.8 the distress zone.
Dividend4/6
Pays a dividend
Monro paid dividends worth 9.7% of the share price over the last twelve months.
Yield above Treasuries
The 9.7% yield is above the 4.4% on a 1-year Treasury.
Yield in the top quarter
The top quarter of US dividend payers yield 3.8% or more; Monro yields 9.7%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Not covered by earnings
Dividends take 4386% of net income, leaving little room.
Not covered by free cash flow
Dividends take 282% of free cash flow.
Fair value
How we estimate itOur estimate per share
$21.65
The share price is 47% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| EV/EBITDA | 9.0× | 8.2× | 9.8× | $19.56 | 70% |
| Earnings power | 9.8% cost of equity | – | – | $26.54 | 30% |
| Fair value | $21.65 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 27.8
- Consumer discretionary median 19.6
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Medium risk
- Average value traded per day
- $11.70M
- Value traded per 1% price move
- $3.92M
Downside
High risk
- Typical loss in a bad month
- 33.6%
- Volatility (annualized)
- 59%
- Sharpe ratio, 1 year
- -0.67
- Beta to the S&P 500 (5Y)
- 0.98
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2012 to 2026
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -3.2% | -4.4% | +0.6% | +2.1% | |
| Gross profit | -3.0% | -3.9% | +0.5% | +0.5% | |
| Operating income | +59.4% | -36.9% | -22.6% | -16.4% | |
| Net income | – | -61.8% | -42.4% | -29.0% | |
| EPS, diluted | – | -70.8% | -50.5% | -34.3% | |
| Free cash flow | -63.3% | -39.6% | -21.9% | -8.0% | |
| Dividend per share | 0.0% | 0.0% | +4.9% | +6.4% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on assets | 5.6% | 1.8% | 0.1% | |
| Current ratio | 1.07 | 0.92 | 0.46 | |
| Net debt to EBITDA | 1.08× | 1.32× | 1.01× | |
| Inventory turnover | 4.6× | 4.2× | 4.5× | |
| Capex to revenue | 3.4% | 4.6% | 2.7% | |
| Diluted shares | 33M | 34M | 30M |
Where the cash went
Fiscal 2022 to 2026, five years combined
Monro generated $716.32M from operations and spent $467.70M on capital expenditure, dividends and share buybacks. 32% of that went back into the business.
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
- ProfitableNet income above zero$2.17M
- Cash generatingOperating cash flow above zero$70.44M
- Return on assets improvedROA up on the prior year-0.3% → 0.1%
- Earnings backed by cashOperating cash flow above net income$70.44M vs $2.17M
- Less leverageLong-term debt to assets fell3.7% → 3.8%
- Better liquidityCurrent ratio rose0.53 → 0.46
- No dilutionShare count did not rise30M → 30M
- Gross margin improvedGross margin up on the prior year34.94% → 35.02%
- More efficientAsset turnover rose0.71 → 0.70
See a number that looks wrong?